Ginkgo Leaf Extract and Armillariella Mellea Powder Oral Solution for the Treatment of Motoric Cognitive Risk Syndrome
Clinical trial NCT04492241 · UNKNOWN
Trial details
- NCT number
- NCT04492241
- Sponsor
- Beijing Tiantan Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2023-12-31
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.